Pathophysiology of RAGE in inflammatory diseases

被引：90

作者：

Dong, Hanbing ^{[1
]}

Zhang, Yue ^{[1
]}

Huang, Yu ^{[1
]}

Deng, Hui ^{[1
]}

机构：

[1] Jilin Univ, Hosp 1, Dept Neurol & Neurosci Ctr, Changchun, Peoples R China

来源：

FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷

关键词：

RAGE; ligands; signaling; inflammatory diseases; RAGE inhibitors; GLYCATION END-PRODUCTS; GROUP BOX 1; CELL-SURFACE-RECEPTOR; A-BETA ACCUMULATION; BLOOD-BRAIN-BARRIER; LYSOPHOSPHATIDIC ACID; S100; PROTEINS; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; OXIDATIVE STRESS;

D O I：

10.3389/fimmu.2022.931473

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The receptor for advanced glycation end products (RAGE) is a non-specific multi-ligand pattern recognition receptor capable of binding to a range of structurally diverse ligands, expressed on a variety of cell types, and performing different functions. The ligand-RAGE axis can trigger a range of signaling events that are associated with diabetes and its complications, neurological disorders, cancer, inflammation and other diseases. Since RAGE is involved in the pathophysiological processes of many diseases, targeting RAGE may be an effective strategy to block RAGE signaling.

引用

页数：16

共 205 条

[71] RAGE: a novel biological and genetic marker for vascular disease
Kalea, Anastasia Z.
Schmidt, Ann Marie
Hudson, Barry I.
[J]. CLINICAL SCIENCE, 2009, 116 (7-8) : 621 - 637
[72] RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer
Kang, R.
Hou, W.
Zhang, Q.
Chen, R.
Lee, Y. J.
Bartlett, D. L.
Lotze, M. T.
Tang, D.
Zeh, H. J.
[J]. CELL DEATH & DISEASE, 2014, 5 : e1480 - e1480
[73] The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
Kang, R.
Tang, D.
Schapiro, N. E.
Livesey, K. M.
Farkas, A.
Loughran, P.
Bierhaus, A.
Lotze, M. T.
Zeh, H. J.
[J]. CELL DEATH AND DIFFERENTIATION, 2010, 17 (04) : 666 - 676
[74] Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis
Kao, Ying-Hsien
Lin, Yu-Chun
Tsai, Ming-Shian
Sun, Cheuk-Kwan
Yuan, Shyng-Shiou
Chang, Chih-Yang
Jawan, Bruno
Lee, Po-Huang
[J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (09): : 1720 - 1732
[75] Blocking the interaction between S100A9 protein and RAGE V domain using S100A12 protein
Katte, Revansiddha
Yu, Chin
[J]. PLOS ONE, 2018, 13 (06):
[76] Hyperglycemia in Stroke Impairs Polarization of Monocytes/Macrophages to a Protective Noninflammatory Cell Type
Khan, Mahtab A.
Schultz, Sina
Othman, Alaa
Fleming, Thomas
Lebron-Galan, Rafael
Rades, Dirk
Clemente, Diego
Nawroth, Peter P.
Schwaninger, Markus
[J]. JOURNAL OF NEUROSCIENCE, 2016, 36 (36) : 9313 - 9325
[77] S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain
Khan, Md. Imran
Su, Yu-Kai
Zou, Jinhao
Yang, Lee-Wei
Chou, Ruey-Hwang
Yu, Chin
[J]. PLOS ONE, 2018, 13 (02):
[78] Non-cell autonomous modulation of tyrosine hydroxylase by HMGB1 released from astrocytes in an acute MPTP-induced Parkinsonian mouse model
Kim, Soo Jeong
Ryu, Min Jeong
Han, Jeongsu
Jang, Yunseon
Lee, Min Joung
Ju, Xianshu
Ryu, Ilhwan
Lee, Yu Lim
Oh, Eungseok
Chung, Woosuk
Heo, Jun Young
Kweon, Gi Ryang
[J]. LABORATORY INVESTIGATION, 2019, 99 (09) : 1389 - 1399
[79] Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone
Kolonin, Mikhail G.
Sergeeva, Anna
Staquicini, Daniela I.
Smith, Tracey L.
Tarleton, Christy A.
Molldrem, Jeffrey J.
Sidman, Richard L.
Marchio, Serena
Pasqualini, Renata
Arap, Wadih
[J]. CANCER RESEARCH, 2017, 77 (12) : 3144 - 3150
[80] Linking RAGE and Nox in diabetic micro- and macrovascular complications
Koulis, C.
Watson, A. M. D.
Gray, S. T.
Jandeleit-Dahm, K. A.
[J]. DIABETES & METABOLISM, 2015, 41 (04) : 272 - 281

← 3 4 5 6 7 8 9 10 11 12 →